C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2007
12/21/2007	WO2007144281A1 Process for alkenylating carboxamides
12/21/2007	WO2007144006A1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007	WO2007127297A3 Crystalline forms of a dimethylphenyl compound
12/21/2007	WO2007127196A3 DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
12/21/2007	WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
12/21/2007	WO2007111706A3 Organic compounds
12/21/2007	WO2007111705A3 Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides
12/21/2007	WO2007062334A8 New pleuromutilin derivative and its use
12/21/2007	CA2784304A1 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007	CA2655282A1 Pharmaceutical use of substituted piperidine carboxamides
12/21/2007	CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists
12/21/2007	CA2654699A1 Benzamide derivatives and uses related thereto
12/21/2007	CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
12/20/2007	US20070293683 N-phenyl-2-pyrimidine-amine derivatives
12/20/2007	US20070293547 Compounds and Compositions as Lxr Modulators
12/20/2007	US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007	US20070293503 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
12/20/2007	US20070293499 Intracellular Kinase Inhibitors
12/20/2007	US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007	US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007	US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists
12/20/2007	US20070293461 Biphenyl compounds useful as muscarinic receptor antagonists
12/20/2007	US20070292471 Nitric Oxide-Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, and Compositions, Medical Devices, and Uses Thereof
12/20/2007	US20070292375 Piperidinium compounds and cosmetic compositions containing them
12/20/2007	US20070292357 Biphenyl compounds useful as muscarinic receptor antagonists
12/20/2007	US20070292356 Biphenyl compounds useful as muscarinic receptor antagonists
12/19/2007	EP1867635A1 Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
12/19/2007	EP1867634A1 Ligand for vesicular acetylcholine transporter
12/19/2007	EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007	EP1866285A1 1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
12/19/2007	EP1866284A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/19/2007	EP1866277A2 Sulfonyl containing compounds as cysteine protease inhibitors
12/19/2007	EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007	EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007	CN101090888A 4-aminopiperidine derivatives
12/19/2007	CN101090883A Substituted hydroxyethylamines
12/19/2007	CN100355729C Pleuromutilin
12/18/2007	US7309787 2-Substituted spiro[cyclopropane-1,3'-indolin-2'-ones]: morpholinylphenyl-, piperidinylethylphenyl-, 3-(carboxyethyl)-4-methylpyrrol-2-yl-, pyrazolon-2-yl-, 4-methylimidazol-5-yl-; vascular endothelial growth factor inhibitors; regulate, modulate and/or inhibit abnormal cell proliferation
12/18/2007	CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/18/2007	CA2219308C New process for the preparation of ropivacaine hydrochloride monohydrate
12/13/2007	WO2007141289A1 Piperidinium compounds and cosmetic compositions containing them
12/13/2007	US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors
12/13/2007	US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
12/13/2007	US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
12/13/2007	US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007	US20070287709 Novel arylamino N-heteraryls as MEK inhibitors
12/13/2007	US20070287697 Cgrp Receptor Antagonists
12/13/2007	US20070286911 Huperzia serrate (thunb.) trev. composition comprising compounded huperzine a and huperzine b and methods for preparing it
12/13/2007	CA2654784A1 Substituted phenylacetic acids as dp-2 antagonists
12/12/2007	EP1863872A1 Novel polymeric hindered amine light stabilizers based on end functionalized polyolefins and a process for the preparation thereof.
12/12/2007	EP1863765A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents
12/12/2007	EP1863764A1 Process for the preparation of opioid modulators
12/12/2007	EP1863763A1 3,4,5-substituted piperidines as renin inhibitors
12/12/2007	EP1863490A2 Muscarinic modulators
12/12/2007	EP1406623B1 Substituted 1-phenethylpiperidine compounds used as inter alia analgesics
12/12/2007	EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
12/12/2007	CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007	CN100354262C Sterically hindered amine compound
12/12/2007	CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
12/11/2007	US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
12/11/2007	US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007	CA2348735C Heterocyclic potassium channel inhibitors
12/06/2007	WO2007140212A2 Tartrate salt of isofagomine and methods of use
12/06/2007	WO2007140184A2 Deoxynojirimycin and d-arabinitol analogs and methods of using
12/06/2007	WO2007139211A1 Process for production of optically active piperidine compound
12/06/2007	WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR
12/06/2007	WO2007137738A1 Spirocyclic nitriles as protease inhibitors
12/06/2007	WO2007117560A3 Piperidine and morpholine renin inhibitors
12/06/2007	WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
12/06/2007	WO2007072143A3 Chemical compounds
12/06/2007	US20070282110 Process for Preparing Diimine Compounds
12/06/2007	US20070281975 Tartrate Salt of Isofagomine and Methods of Use
12/06/2007	US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007	US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007	CA2653662A1 Spirocyclic nitriles as protease inhibitors
12/06/2007	CA2652958A1 Deoxynojirimycin and d-arabinitol analogs and methods of using
12/05/2007	EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007	EP1862442A1 Process for oxidation of organic compounds
12/05/2007	EP1861358A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same
12/05/2007	EP1861357A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/05/2007	CN101084191A Process for making substituted piperidines
12/05/2007	CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/05/2007	CN101081830A Spiro [benzo ring-2-ketone-3-(4'-piperidine)] template compound and preparation method of its derivative
12/05/2007	CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007	CN100352818C Improved method of preparing azhediping
12/05/2007	CN100352816C Nociceptin analogs
12/05/2007	CN100352807C Chemical compounds
12/05/2007	CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007	CN100352499C High mannose proteins and method of making mannose proteins
12/04/2007	US7304167 Biphenylcarboxamides useful as lipid lowering agents
12/04/2007	US7304165 Combination libraries
12/04/2007	US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols
12/04/2007	US7304094 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase
12/04/2007	US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007	US7304077 Asthma, rhinitis therapy
12/04/2007	US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007	US7304065 Melanin concentrating hormone antagonists
12/04/2007	US7304057 Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator
12/04/2007	US7304053 Glycoprotein-mediated MDR
12/04/2007	CA2280753C 1,4-substituted cyclic amine derivatives

1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 380